ArticleNeuro-oncology advances

Postoperative NEOadjuvant TEMozolomide followed by chemoradiotherapy versus upfront chemoradiotherapy for glioblastoma multiforme (NEOTEM) trial: Interim results.

Azadeh Sharifian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.